Apnar Pharma
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4820 Lanier Rd, Chino, California, 91710...Phone Number
(844) 283-9825Website
www.apnarpharma.comRevenue
<$5 MillionIndustry
About Apnar Pharma
Apnar Pharma is a privately owned and rapidly growing pharmaceutical company that focuses on the acquisition, licensing, development, sales, marketing, and distribution of generic pharmaceuticals and OTC products for the U.S. market. The company aims to provide high-standard products to clients in the pharmaceutical industry while expanding access to scarce pharmaceutical products globally. Apnar Pharma offers a variety of dosage forms, including tablets and capsules, and provides services such as preformulation studies, impurity profiling, and analytical method development. They actively participate in major trade shows to enhance their business development and strategic partnerships.Explore more
SIC Code 28,283NAICS Code 32,325Show moreApnar Pharma Org Chart
Compare Similar Companies to Apnar Pharma
Compare insights from companies similar to Apnar Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Apnar Pharma
<$5M
51-200
Private
-
2014
DV
Digpalsinh VaghelaAssistant General Manager, Project Management
Apnar Pharma Tech Stack
A closer look at the technologies used by Apnar Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Apnar Pharma
Sign Up For FreeTo access detailed company insights
Apnar Pharma is a privately owned and rapidly growing pharmaceutical company that focuses on the acquisition, licensing, development, sales, marketing, and distribution of generic pharmaceuticals and OTC products for the U.S. market. The company aims to provide high-standard products to clients in the pharmaceutical industry while expanding access... Read More